{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:34:50Z","timestamp":1789601690904,"version":"build-2803163510"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The therapeutic options for Alzheimer\u2019s disease (AD) are limited, underscoring the critical need for finding an effective regulator of A\u03b242 production. In this study, with 489 human postmortem brains, we revealed that homotrimer G protein subunit gamma 5 (GNG5) expression is upregulated in the hippocampal\u2013entorhinal region of pathological AD compared with normal controls, and is positively correlated with A\u03b2 pathology. In vivo and in vitro experiments confirm that increased GNG5 significantly promotes A\u03b2 pathology and A\u03b242 production. Mechanically, GNG5 regulates the cleavage preference of \u03b3-secretase towards A\u03b242 by directly interacting with the \u03b3-secretase catalytic subunit presenilin 1 (PS1). Moreover, excessive GNG5 increases the protein levels and the activation of Rab5, leading to the increased number of early endosomes, the major cellular organelle for production of A\u03b242. Furthermore, immunoprecipitation and immunofluorescence revealed co-interaction of A\u03b242 with GPCR family CXCR2, which is known as the receptor for IL-8, thus facilitating the dissociation of G-proteins \u03b2\u03b3 from \u03b1 subunits. Treatment of A\u03b242 in neurons combined with structure prediction indicated A\u03b242 oligomers as a new ligand of CXCR2, upregulating \u03b3 subunit GNG5 protein levels. The co-localizations of GNG5 and PS1, CXCR2 and A\u03b242 were verified in eight human brain regions. Besides, GNG5 is significantly reduced in extracellular vesicles (EVs) derived from cerebral cortex or serum of AD patients compared with healthy cognition controls. In brief, GNG5 is a novel regulator of A\u03b242 production, suggesting its clinical potential as a diagnosis biomarker and the therapeutic target for AD.<\/jats:p>","DOI":"10.1038\/s41419-024-07218-z","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T11:51:04Z","timestamp":1731325864000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["GNG5 is a novel regulator of A\u03b242 production in Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"15","author":[{"given":"Chunyuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenying","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9907-512X","authenticated-orcid":false,"given":"Wei","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,11]]},"reference":[{"key":"7218_CR1","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","volume":"8","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen H, Li R, Sterling K, Song W. Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: challenges, successes and future. Signal Transduct Target Ther. 2023;8:248.","journal-title":"Signal Transduct Target Ther"},{"key":"7218_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neuron.2008.02.003","volume":"58","author":"JR Cirrito","year":"2008","unstructured":"Cirrito JR, Kang JE, Lee J, Stewart FR, Verges DK, Silverio LM, et al. Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo. Neuron. 2008;58:42\u201351.","journal-title":"Neuron"},{"key":"7218_CR3","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1038\/s41591-023-02505-2","volume":"29","author":"WK Self","year":"2023","unstructured":"Self WK, Holtzman DM. Emerging diagnostics and therapeutics for Alzheimer disease. Nat Med. 2023;29:2187\u201399.","journal-title":"Nat Med"},{"key":"7218_CR4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMoa1210951","volume":"369","author":"RS Doody","year":"2013","unstructured":"Doody RS, Raman R, Farlow M, Iwatsubo T, Vellas B, Joffe S, et al. A phase 3 trial of semagacestat for treatment of Alzheimer\u2019s disease. N Engl J Med. 2013;369:341\u201350.","journal-title":"N Engl J Med"},{"key":"7218_CR5","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1038\/s43587-023-00523-w","volume":"3","author":"M Shulman","year":"2023","unstructured":"Shulman M, Kong J, O\u2019Gorman J, Ratti E, Rajagovindan R, Viollet L, et al. TANGO: a placebo-controlled randomized phase 2 study of efficacy and safety of the anti-tau monoclonal antibody gosuranemab in early Alzheimer\u2019s disease. Nat Aging. 2023;3:1591\u2013601.","journal-title":"Nat Aging"},{"key":"7218_CR6","doi-asserted-by":"crossref","unstructured":"Bottero V, Powers D, Yalamanchi A, Quinn JP, Potashkin JA. Key disease mechanisms linked to Alzheimer\u2019s disease in the entorhinal cortex. Int J Mol Sci. 2021;22:3915.","DOI":"10.3390\/ijms22083915"},{"key":"7218_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-022-03123-4","volume":"12","author":"YL Rao","year":"2022","unstructured":"Rao YL, Ganaraja B, Murlimanju BV, Joy T, Krishnamurthy A, Agrawal A. Hippocampus and its involvement in Alzheimer\u2019s disease: a review. 3 Biotech. 2022;12:55.","journal-title":"3 Biotech"},{"key":"7218_CR8","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/nn.3606","volume":"17","author":"UA Khan","year":"2014","unstructured":"Khan UA, Liu L, Provenzano FA, Berman DE, Profaci CP, Sloan R, et al. Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer\u2019s disease. Nat Neurosci. 2014;17:304\u201311.","journal-title":"Nat Neurosci"},{"key":"7218_CR9","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nature11133","volume":"485","author":"A Zeigerer","year":"2012","unstructured":"Zeigerer A, Gilleron J, Bogorad RL, Marsico G, Nonaka H, Seifert S, et al. Rab5 is necessary for the biogenesis of the endolysosomal system in vivo. Nature. 2012;485:465\u201370.","journal-title":"Nature"},{"key":"7218_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33881-x","volume":"13","author":"H Park","year":"2022","unstructured":"Park H, Hundley FV, Yu Q, Overmyer KA, Brademan DR, Serrano L, et al. Spatial snapshots of amyloid precursor protein intramembrane processing via early endosome proteomics. Nat Commun. 2022;13:6112.","journal-title":"Nat Commun"},{"key":"7218_CR11","doi-asserted-by":"crossref","unstructured":"Baek MS, Lee N, Kim JW, Hong JY. Association of hippocampal subfield volumes with amyloid-beta deposition in Alzheimer\u2019s disease. J Clin Med. 2022;11:1526.","DOI":"10.3390\/jcm11061526"},{"key":"7218_CR12","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1126\/science.2111583","volume":"248","author":"FS Esch","year":"1990","unstructured":"Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR, Oltersdorf T, et al. Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science. 1990;248:1122\u20134.","journal-title":"Science"},{"key":"7218_CR13","doi-asserted-by":"publisher","first-page":"6138","DOI":"10.1073\/pnas.110126897","volume":"97","author":"YM Li","year":"2000","unstructured":"Li YM, Lai MT, Xu M, Huang Q, DiMuzio-Mower J, Sardana MK, et al. Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state. Proc Natl Acad Sci USA. 2000;97:6138\u201343.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7218_CR14","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cell.2020.11.049","volume":"184","author":"G Yang","year":"2021","unstructured":"Yang G, Zhou R, Guo X, Yan C, Lei J, Shi Y. Structural basis of gamma-secretase inhibition and modulation by small molecule drugs. Cell. 2021;184:521\u201333 e14.","journal-title":"Cell"},{"key":"7218_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.974890","volume":"15","author":"RA DeGiosio","year":"2022","unstructured":"DeGiosio RA, Grubisha MJ, MacDonald ML, McKinney BC, Camacho CJ, Sweet RA. More than a marker: potential pathogenic functions of MAP2. Front Mol Neurosci. 2022;15:974890.","journal-title":"Front Mol Neurosci"},{"key":"7218_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32130-5","volume":"13","author":"A Lee","year":"2022","unstructured":"Lee A, Kondapalli C, Virga DM, Lewis TL Jr, Koo SY, Ashok A, et al. Abeta42 oligomers trigger synaptic loss through CAMKK2-AMPK-dependent effectors coordinating mitochondrial fission and mitophagy. Nat Commun. 2022;13:4444.","journal-title":"Nat Commun"},{"key":"7218_CR17","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.4103\/1673-5374.385854","volume":"19","author":"A Huo","year":"2024","unstructured":"Huo A, Wang J, Li Q, Li M, Qi Y, Yin Q, et al. Molecular mechanisms underlying microglial sensing and phagocytosis in synaptic pruning. Neural Regen Res. 2024;19:1284\u201390.","journal-title":"Neural Regen Res"},{"key":"7218_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03733-8","volume":"9","author":"R Kojima","year":"2018","unstructured":"Kojima R, Bojar D, Rizzi G, Hamri GC, El-Baba MD, Saxena P, et al. Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson\u2019s disease treatment. Nat Commun. 2018;9:1305.","journal-title":"Nat Commun"},{"key":"7218_CR19","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.jconrel.2022.06.011","volume":"348","author":"S Bashyal","year":"2022","unstructured":"Bashyal S, Thapa C, Lee S. Recent progresses in exosome-based systems for targeted drug delivery to the brain. J Control Release. 2022;348:723\u201344.","journal-title":"J Control Release"},{"key":"7218_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12979-019-0150-2","volume":"16","author":"GH Cui","year":"2019","unstructured":"Cui GH, Guo HD, Li H, Zhai Y, Gong ZB, Wu J, et al. RVG-modified exosomes derived from mesenchymal stem cells rescue memory deficits by regulating inflammatory responses in a mouse model of Alzheimer\u2019s disease. Immun Ageing. 2019;16:10.","journal-title":"Immun Ageing"},{"key":"7218_CR21","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1177\/026010600601800307","volume":"18","author":"GM Cole","year":"2006","unstructured":"Cole GM, Frautschy SA. Docosahexaenoic acid protects from amyloid and dendritic pathology in an Alzheimer\u2019s disease mouse model. Nutr Health. 2006;18:249\u201359.","journal-title":"Nutr Health"},{"key":"7218_CR22","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/19077","volume":"398","author":"MS Wolfe","year":"1999","unstructured":"Wolfe MS, Xia W, Ostaszewski BL, Diehl TS, Kimberly WT, Selkoe DJ. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature. 1999;398:513\u20137.","journal-title":"Nature"},{"key":"7218_CR23","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1126\/science.1738847","volume":"255","author":"TE Golde","year":"1992","unstructured":"Golde TE, Estus S, Younkin LH, Selkoe DJ, Younkin SG. Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science. 1992;255:728\u201330.","journal-title":"Science"},{"key":"7218_CR24","doi-asserted-by":"publisher","first-page":"31261","DOI":"10.1074\/jbc.M304122200","volume":"278","author":"OM Grbovic","year":"2003","unstructured":"Grbovic OM, Mathews PM, Jiang Y, Schmidt SD, Dinakar R, Summers-Terio NB, et al. Rab5-stimulated up-regulation of the endocytic pathway increases intracellular beta-cleaved amyloid precursor protein carboxyl-terminal fragment levels and Abeta production. J Biol Chem. 2003;278:31261\u20138.","journal-title":"J Biol Chem"},{"key":"7218_CR25","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1124\/jpet.106.118927","volume":"322","author":"W Gonsiorek","year":"2007","unstructured":"Gonsiorek W, Fan X, Hesk D, Fossetta J, Qiu H, Jakway J, et al. Pharmacological characterization of Sch527123, a potent allosteric CXCR1\/CXCR2 antagonist. J Pharm Exp Ther. 2007;322:477\u201385.","journal-title":"J Pharm Exp Ther"},{"key":"7218_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41586-020-2492-5","volume":"585","author":"K Liu","year":"2020","unstructured":"Liu K, Wu L, Yuan S, Wu M, Xu Y, Sun Q, et al. Structural basis of CXC chemokine receptor 2 activation and signalling. Nature. 2020;585:135\u201340.","journal-title":"Nature"},{"key":"7218_CR27","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.4049\/jimmunol.1201114","volume":"189","author":"SK Raghuwanshi","year":"2012","unstructured":"Raghuwanshi SK, Su Y, Singh V, Haynes K, Richmond A, Richardson RM. The chemokine receptors CXCR1 and CXCR2 couple to distinct G protein-coupled receptor kinases to mediate and regulate leukocyte functions. J Immunol. 2012;189:2824\u201332.","journal-title":"J Immunol"},{"key":"7218_CR28","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/febs.15865","volume":"289","author":"K Liu","year":"2022","unstructured":"Liu K, Shen L, Wu M, Liu ZJ, Hua T. Structural insights into the activation of chemokine receptor CXCR2. FEBS J. 2022;289:386\u201393.","journal-title":"FEBS J"},{"key":"7218_CR29","volume":"9","author":"J Cummings","year":"2023","unstructured":"Cummings J, Zhou Y, Lee G, Zhong K, Fonseca J, Cheng F. Alzheimer\u2019s disease drug development pipeline: 2023. Alzheimers Dement. 2023;9:e12385","journal-title":"Alzheimers Dement"},{"key":"7218_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12929-023-00976-6","volume":"30","author":"LK Huang","year":"2023","unstructured":"Huang LK, Kuan YC, Lin HW, Hu CJ. Clinical trials of new drugs for Alzheimer disease: a 2020-2023 update. J Biomed Sci. 2023;30:83.","journal-title":"J Biomed Sci"},{"key":"7218_CR31","doi-asserted-by":"publisher","first-page":"6959","DOI":"10.1073\/pnas.96.12.6959","volume":"96","author":"W Song","year":"1999","unstructured":"Song W, Nadeau P, Yuan M, Yang X, Shen J, Yankner BA. Proteolytic release and nuclear translocation of Notch-1 are induced by presenilin-1 and impaired by pathogenic presenilin-1 mutations. Proc Natl Acad Sci USA. 1999;96:6959\u201363.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7218_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ebiom.2017.08.028","volume":"24","author":"F Raven","year":"2017","unstructured":"Raven F, Ward JF, Zoltowska KM, Wan Y, Bylykbashi E, Miller SJ, et al. Soluble gamma-secretase modulators attenuate Alzheimer\u2019s \u03b2-amyloid pathology and induce conformational changes in presenilin 1. eBioMedicine. 2017;24:93\u2013101.","journal-title":"eBioMedicine"},{"key":"7218_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1750-1326-7-61","volume":"7","author":"K Rogers","year":"2012","unstructured":"Rogers K, Felsenstein KM, Hrdlicka L, Tu Z, Albayya F, Lee W, et al. Modulation of \u03b3-secretase by EVP-0015962 reduces amyloid deposition and behavioral deficits in Tg2576 mice. Mol Neurodegener. 2012;7:61.","journal-title":"Mol Neurodegener"},{"key":"7218_CR34","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.biotechadv.2017.12.010","volume":"36","author":"AA Farooqi","year":"2018","unstructured":"Farooqi AA, Desai NN, Qureshi MZ, Librelotto DRN, Gasparri ML, Bishayee A, et al. Exosome biogenesis, bioactivities and functions as new delivery systems of natural compounds. Biotechnol Adv. 2018;36:328\u201334.","journal-title":"Biotechnol Adv"},{"key":"7218_CR35","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1515\/hsz-2016-0274","volume":"398","author":"RS Goody","year":"2017","unstructured":"Goody RS, M\u00fcller MP, Wu YW. Mechanisms of action of Rab proteins, key regulators of intracellular vesicular transport. Biol Chem. 2017;398:565\u201375.","journal-title":"Biol Chem"},{"key":"7218_CR36","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1146\/annurev.pharmtox.46.120604.141115","volume":"46","author":"M Sato","year":"2006","unstructured":"Sato M, Blumer JB, Simon V, Lanier SM. Accessory proteins for G proteins: partners in signaling. Annu Rev Pharm Toxicol. 2006;46:151\u201387.","journal-title":"Annu Rev Pharm Toxicol"},{"key":"7218_CR37","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.neuron.2018.01.031","volume":"97","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Wu X, Li X, Jiang LL, Gui X, Liu Y, et al. TREM2 is a receptor for \u03b2-amyloid that mediates microglial function. Neuron. 2018;97:1023\u201331.e7.","journal-title":"Neuron"},{"key":"7218_CR38","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.bbrc.2011.07.127","volume":"412","author":"Ashutosh","year":"2011","unstructured":"Ashutosh, Kou W, Cotter R, Borgmann K, Wu L, Persidsky R, et al. CXCL8 protects human neurons from amyloid-\u03b2-induced neurotoxicity: relevance to Alzheimer\u2019s disease. Biochem Biophys Res Commun. 2011;412:565\u201371.","journal-title":"Biochem Biophys Res Commun"},{"key":"7218_CR39","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1097\/00001756-200308060-00025","volume":"14","author":"A Garc\u00eda-Jim\u00e9nez","year":"2003","unstructured":"Garc\u00eda-Jim\u00e9nez A, Fastbom J, Ohm TG, Cowburn RF. G-protein alpha-subunit levels in hippocampus and entorhinal cortex of brains staged for Alzheimer\u2019s disease neurofibrillary and amyloid pathologies. Neuroreport. 2003;14:1523\u20137.","journal-title":"Neuroreport"},{"key":"7218_CR40","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/dnares\/7.2.111","volume":"7","author":"EH Hurowitz","year":"2000","unstructured":"Hurowitz EH, Melnyk JM, Chen YJ, Kouros-Mehr H, Simon MI, Shizuya H. Genomic characterization of the human heterotrimeric G protein alpha, beta, and gamma subunit genes. DNA Res. 2000;7:111\u201320.","journal-title":"DNA Res"},{"key":"7218_CR41","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1124\/pr.111.005603","volume":"65","author":"SM Khan","year":"2013","unstructured":"Khan SM, Sleno R, Gora S, Zylbergold P, Laverdure JP, Labbe JC, et al. The expanding roles of Gbetagamma subunits in G protein-coupled receptor signaling and drug action. Pharm Rev. 2013;65:545\u201377.","journal-title":"Pharm Rev"},{"key":"7218_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1895\/wormbook.1.75.2","volume":"2018","author":"MR Koelle","year":"2018","unstructured":"Koelle MR. Neurotransmitter signaling through heterotrimeric G proteins: insights from studies in C. elegans. WormBook. 2018;2018:1\u201352.","journal-title":"WormBook"},{"key":"7218_CR43","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0014-5793(93)80971-V","volume":"328","author":"AN Pronin","year":"1993","unstructured":"Pronin AN, Gautam N. Proper processing of a G protein gamma subunit depends on complex formation with a beta subunit. FEBS Lett. 1993;328:89\u201393.","journal-title":"FEBS Lett"},{"key":"7218_CR44","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","volume":"15","author":"Y Hou","year":"2019","unstructured":"Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch SG, Croteau DL, et al. Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol. 2019;15:565\u201381.","journal-title":"Nat Rev Neurol"},{"key":"7218_CR45","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v4.26659","volume":"4","author":"KR Jakobsen","year":"2015","unstructured":"Jakobsen KR, Paulsen BS BaekR, Varming K, Sorensen BS, Jorgensen MM. Exosomal proteins as potential diagnostic markers in advanced non-small cell lung carcinoma. J Extracell Vesicles. 2015;4:26659.","journal-title":"J Extracell Vesicles"},{"key":"7218_CR46","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1038\/s41591-024-02937-4","volume":"30","author":"M Chatterjee","year":"2024","unstructured":"Chatterjee M, Ozdemir S, Fritz C, Mobius W, Kleineidam L, Mandelkow E, et al. Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS. Nat Med. 2024;30:1771\u201383.","journal-title":"Nat Med"},{"key":"7218_CR47","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41392-024-01735-1","volume":"9","author":"MA Kumar","year":"2024","unstructured":"Kumar MA, Baba SK, Sadida HQ, Marzooqi SA, Jerobin J, Altemani FH, et al. Extracellular vesicles as tools and targets in therapy for diseases. Signal Transduct Target Ther. 2024;9:27.","journal-title":"Signal Transduct Target Ther"},{"key":"7218_CR48","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41392-020-00258-9","volume":"5","author":"B Zhou","year":"2020","unstructured":"Zhou B, Xu K, Zheng X, Chen T, Wang J, Song Y, et al. Application of exosomes as liquid biopsy in clinical diagnosis. Signal Transduct Target Ther. 2020;5:144.","journal-title":"Signal Transduct Target Ther"},{"key":"7218_CR49","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41586-021-03828-1","volume":"596","author":"K Tunyasuvunakool","year":"2021","unstructured":"Tunyasuvunakool K, Adler J, Wu Z, Green T, Zielinski M, Zidek A, et al. Highly accurate protein structure prediction for the human proteome. Nature. 2021;596:590\u20136.","journal-title":"Nature"},{"key":"7218_CR50","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1093\/brain\/awv128","volume":"138","author":"DB Wang","year":"2015","unstructured":"Wang DB, Kinoshita Y, Kinoshita C, Uo T, Sopher BL, Cudaback E, et al. Loss of endophilin-B1 exacerbates Alzheimer\u2019s disease pathology. Brain. 2015;138:2005\u201319.","journal-title":"Brain"},{"key":"7218_CR51","doi-asserted-by":"crossref","unstructured":"Choi SH, Bylykbashi E, Chatila ZK, Lee SW, Pulli B, Clemenson GD, et al. Combined adult neurogenesis and BDNF mimic exercise effects on cognition in an Alzheimer\u2019s mouse model. Science. 2018;361:eaan8821.","DOI":"10.1126\/science.aan8821"},{"key":"7218_CR52","doi-asserted-by":"publisher","first-page":"0180","DOI":"10.34133\/research.0180","volume":"6","author":"Q Huang","year":"2023","unstructured":"Huang Q, Jiang C, Xia X, Wang Y, Yan C, Wang X, et al. Pathological BBB crossing melanin-like nanoparticles as metal-ion chelators and neuroinflammation regulators against Alzheimer\u2019s disease. Research. 2023;6:0180.","journal-title":"Research"},{"key":"7218_CR53","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s12264-018-0306-7","volume":"35","author":"W Qiu","year":"2019","unstructured":"Qiu W, Zhang H, Bao A, Zhu K, Huang Y, Yan X, et al. Standardized operational protocol for human brain banking in China. Neurosci Bull. 2019;35:270\u20136.","journal-title":"Neurosci Bull"},{"key":"7218_CR54","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13047","volume":"32","author":"Y Gao","year":"2022","unstructured":"Gao Y, Liu J, Wang J, Liu Y, Zeng LH, Ge W, et al. Proteomic analysis of human hippocampal subfields provides new insights into the pathogenesis of Alzheimer\u2019s disease and the role of glial cells. Brain Pathol. 2022;32:e13047.","journal-title":"Brain Pathol"},{"key":"7218_CR55","doi-asserted-by":"crossref","unstructured":"Luo D, Li J, Liu H, Wang J, Xia Y, Qiu W, et al. Integrative transcriptomic analyses of hippocampal-entorhinal system subfields identify key regulators in Alzheimer\u2019s disease. Adv Sci. 2023;10:e2300876.","DOI":"10.1002\/advs.202300876"},{"key":"7218_CR56","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nbt.1807","volume":"29","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011;29:341\u20135.","journal-title":"Nat Biotechnol"},{"key":"7218_CR57","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jconrel.2013.08.014","volume":"172","author":"SAA Kooijmans","year":"2013","unstructured":"Kooijmans SAA, Stremersch S, Braeckmans K, de Smedt SC, Hendrix A, Wood MJA, et al. Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles. J Control Release. 2013;172:229\u201338.","journal-title":"J Control Release"},{"key":"7218_CR58","doi-asserted-by":"crossref","unstructured":"Kovalska M, Hnilicova P, Kalenska D, Tothova B, Adamkov M, Lehotsky J. Effect of methionine diet on metabolic and histopathological changes of rat hippocampus. Int J Mol Sci. 2019;20:6234.","DOI":"10.3390\/ijms20246234"},{"key":"7218_CR59","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1093\/bioinformatics\/btu097","volume":"30","author":"BG Pierce","year":"2014","unstructured":"Pierce BG, Wiehe K, Hwang H, Kim BH, Vreven T, Weng Z. ZDOCK server: interactive docking prediction of protein-protein complexes and symmetric multimers. Bioinformatics. 2014;30:1771\u20133.","journal-title":"Bioinformatics"},{"key":"7218_CR60","doi-asserted-by":"publisher","first-page":"W233","DOI":"10.1093\/nar\/gkn216","volume":"36","author":"S Lyskov","year":"2008","unstructured":"Lyskov S, Gray JJ. The RosettaDock server for local protein-protein docking. Nucleic Acids Res. 2008;36:W233\u20138.","journal-title":"Nucleic Acids Res"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-024-07218-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-024-07218-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-024-07218-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T04:54:18Z","timestamp":1731473658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-024-07218-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,11]]},"references-count":60,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["7218"],"URL":"https:\/\/doi.org\/10.1038\/s41419-024-07218-z","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,11]]},"assertion":[{"value":"14 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Human material study has been approved by the Ethics Committee of the Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences. The ethics approval for animal work was provided by the Ethics Committee of Chinese Academy of Medical Sciences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"815"}}